Form C - Offering Statement:
SEC Accession No. 0001787792-26-000005
Filing Date
2026-04-17
Accepted
2026-04-17 13:10:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9674
2 OFFERING CIRCULAR fwofferingcircularcf11.pdf EX-99 1279508
  Complete submission text file 0001787792-26-000005.txt   1769838
Mailing Address 630 FLUSHING AVENUE, BOX 104 BROOKLYN NY 11206
Business Address 515 MADISON AVENUE NEW YORK NY 10022 917-930-4332
Fisher Wallace Laboratories, Inc. (Filer) CIK: 0001787792 (see all company filings)

EIN.: 208131183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-37002 | Film No.: 26870786
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)